Synthesis and pharmacological properties of substituted cinnamohydroxamic acids.
D000700:Analgesics / Q000627:therapeutic use; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002351:Carrageenan; D002934:Cinnamates / Q000627:therapeutic use*; D004487:Edema / Q000139:chemically induced / Q000188:drug therapy; D005334:Fever / Q000188:drug therapy; D006168:Guinea Pigs; D006877:Hydroxamic Acids / Q000627:therapeutic use*; D007082:Ileum / Q000187:drug effects; D007249:Inflammation / Q000188:drug therapy; D008297:Male; D010146:Pain / Q000188:drug therapy; D010276:Parasympatholytics / Q000627:therapeutic use; D011817:Rabbits; D051381:Rats
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D002934:Cinnamates; D006877:Hydroxamic Acids; D010276:Parasympatholytics; D002351:Carrageenan